Related Experiment Videos
Allosteric ribozymes sensitive to the second messengers cAMP and cGMP
M Koizumi1, J N Kerr, G A Soukup
1Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA.
Nucleic Acids Symposium Series
|April 26, 2000
Summary
Scientists engineered novel allosteric ribozymes activated by specific cyclic nucleotides. This breakthrough combines rational design with selection to create responsive molecular tools for potential therapeutic applications.
Area of Science:
- Molecular Biology
- Biochemistry
- Synthetic Biology
Background:
- Allosteric ribozymes are RNA molecules that can be regulated by small molecules.
- Engineering specific ligand-binding and catalytic activity into ribozymes remains a challenge.
Purpose of the Study:
- To develop a novel method for engineering allosteric ribozymes with high specificity.
- To create ribozymes that are activated by specific nucleoside 3',5'-cyclic monophosphates (cNMPs).
Main Methods:
- Combined modular rational design with combinatorial strategies.
- Attached a random-sequence domain to hammerhead ribozymes via a communication module.
- Utilized in vitro selection to isolate effector-specific ribozymes.
Main Results:
- Successfully engineered allosteric ribozymes activated by specific cNMPs.
- Isolated ribozymes responsive to cyclic guanosine monophosphate (cGMP), cyclic cytidine monophosphate (cCMP), and cyclic adenosine monophosphate (cAMP).
- Characterized the specificity and responsiveness of the engineered ribozymes.
Conclusions:
- The described methods are effective for engineering allosteric ribozymes.
- This approach holds promise for creating new ligand-specific aptamers and RNA-based therapeutics.